Texas Pharmaceutical and Therapeutics Committee

The Texas Pharmaceutical and Therapeutics Committee (P&T) is established for the purpose of developing recommendations for preferred drugs lists adopted by the Health and Human Services Commission (HHSC). In developing those recommendations the committee shall consider the clinical efficacy, safety, cost-effectiveness and any program benefit associated with a drug product. The Committee was mandated by House Bill 2292, 78^th Legislature, Regular Session, 2003.

Texas Government Code, Section 531.074 requires the appointment of committee members by the Governor. The committee consists of six physicians and five pharmacists actively participating in the Medicaid program.

The Pharmaceutical and Therapeutics Committee meeting schedule for 2010 is:

• February 26, 2010 (Winters PHR)
• June 4, 2010 (Winters PHR) [Agenda]
• August 20, 2010 (Winters PHR) [Agenda]
• November 19, 2010 (Winters PHR)

Likely drug class review schedule for the Medicaid Preferred Drug List for 2010.

The drug class review schedule may change as necessary.

Please check this site regularly, for new and updated information.

Members of the public who wish to testify must register at the meeting site from 8:00am – 9:00am on the morning of the meeting. Each speaker must identify on the registration form the therapeutic drug class and the specific drug(s) on which they will be giving testimony. Registration to testify will also include the name of the person wishing to testify, address and the organization represented. Registrants are required to disclose on the registration form and in their opening testimony if they are speaking on behalf of any organization or pharmaceutical manufacturer. Each pharmaceutical manufacturer will be limited to one speaker for each drug product under review. Testimony may be time limited at the direction of the Chairperson and also may be limited to restrict redundant or repetitive testimony.

Written materials relating to drug classes scheduled for review may be submitted for consideration to: (written material in excess of 2 pages in length should be submitted by mail only and should consist of 12 copies for distribution to Committee members)

Health and Human Services Commission
Vendor Drug Program/Drug Use Review MC-H630
1100 West 49th Street
Austin, TX 78756
Email: TxPandT@hhsc.state.tx.us

This site is designed to provide updates on the activities of Texas' Pharmaceutical and Therapeutics Committee

Some documents linked to from this webpage are in Adobe Acrobat (PDF) format. If you need the free Adobe Acrobat Reader, you can download it here. Access.adobe.com provides a set of free tools that may allow visually disabled users to read documents in Adobe PDF format.